Posts
✅EMBC- The mistake of the Retail Investor is to rely entirely on AI. Setting her the wrong algorithms, thereby missing the most important moments. Which is not available for AI.‼️
One of the biggest mistakes many retail investors make is asking AI simple questions like: **“Is Embecta a good investment?”** or **“What’s wrong with EMBC?”** AI usually responds with a generic, surface-level summary based on the same headlines everyone has already seen: the earnings miss, lowered guidance, GLP-1 concerns, the …
The hardest part of building an AI ecosystem is connecting the pieces.
Buying AI tools is easy. Every company can license a model. Hard paet is making separate tools talk to each other and provide insight that improves decisions. NRED has MetalCore for geological intelligence. And now they're evaluating EyeX for computer vision for operational tweaks. They hired a CTO with a …
Possible buyout $vwav $svre
Enterprise Value (EV) Baseline: As of mid-2026, SaverOne’s raw Enterprise Value sits at approximately $89.9 million. This factors in its equity, total debts, and available cash. An outright corporate buyout of SaverOne 2014 Ltd. (Nasdaq: SVRE) is estimated to cost between $110 million and $175 million, depending on the acquisition …
Get In NOW! This Stock will make millionaires by 2029
$FVRR - the market is valuing a cash machine at almost nothing Lead with the balance sheet, because it's absurd. Market cap: \~$400M Net cash: \~$280M (roughly 70% of the entire market cap is just sitting in the bank) Enterprise value: \~$140M FY2025 free cash flow: \~$104M Read that again. …
🗞️ QSEGF news
Yooo So first major sale from a globally renowned financial company in malaysia 🔥 Hate when they don’t say what company though ( i understand why just hate they don’t) Honestly was just posting to vent i feel like its the start of a validation that QSE does qork and …
embecta -EMBC ✅
Deadline August 5. Buyback-100 mln $$$. EMBC is starting to look more and more interesting. Institutional filings continue to come in, and several funds have increased their positions despite the stock trading near multi-year lows. The $100 million share repurchase authorization remains in place, and if the company has already …
YHC! Where my alckies at! Can you tell me what pattern this is?
I'd like to ask Jim, Jack and Jose if it'd be wise to throw some extra cash at YHC. I'm calling it the L pattern that could turn into a U pattern if you drink enough LQR. Just did a reverse split. Does it have a fighting chance? Does anyone …
SonicStrategy (CAN $SONI : USA: $SONIF) AI Infrastructure Entry: How It Works + New Data Center / Compute Revenue Model
They're transitioning from **blockchain validator/staking ops** into **decentralized AI compute** via the ARKLAB AI asset acquisition. Here's the breakdown: # 1. How They're Getting In (The "Add-Ins" / Entry Mechanism) * **The Deal**: Non-binding LOI to acquire proprietary **software + IP** from ARKLAB AI. This isn't buying a full company …
Spero Therapeutics Changing focus
Spero Therapeutics has purchased an asset from Innovent Biologics, a Chinese biotech/pharma that has relationships already with Pfizer and Lilly among others. To do this, they monetized future royalty payments from GSK on their Tebipenem Hbr asset. Stock is down today based on this change in direction/focus. Spero monetized the …